To Evaluate the Safety, Tolerability and Efficacy of R2R01 Combined With SOC as Compared to SOC Alone in Outpatients With Worsening Heart Failure (WHF)
PHASE2
This Study Aims to Evaluate the Safety, Tolerability and Efficacy of R2R01 ...
Pharmacokinetics and Tolerability of Subcutaneous Dupilumab Coformulated With Berahyaluronidase Alfa and Dupilumab Without Berahyaluronidase Alfa in Healthy Participants
PHASE1
This is a Phase 1 study with 2 parallel groups of healthy participants. Par...
Status
Active Not Recruiting
Location
Clinical Pharmacology of Miami- Site Number : 8400001
A Single Dose Study of LY2189265 in Subjects With Varying Degrees of Hepatic (Liver) Impairment
PHASE1
The primary purpose of this study is to help answer the following research ...
Status
Completed
Location
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Phase I Study to Evaluate Pharmacokinetics, Efficacy and Safety of CT-P13 Subcutaneous in Patients With Active Crohn's Disease and Ulcerative Colitis
PHASE1
Phase 1 randomized, open-label, multicenter, parallel-group study designed ...
A Study to Compare Subcutaneous Versus Intravenous Administration of RoActemra/Actemra (Tocilizumab) in Participants With Moderate to Severe Active Rheumatoid Arthritis
PHASE3
This randomized, double-blind, parallel group study compares the efficacy a...